Clinical implications of the glucokinase impaired function – GCK MODY today
Authors:
- 2 November 2020
- journal article
- review article
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 69 (6) , 995-1011
Abstract
Heterozygous inactivating mutations of the glucokinase (GCK) gene are causing GCK-MODY, one of the most common forms of the Maturity Onset Diabetes of the Young (MODY). GCK-MODY is characterized by fasting hyperglycemia without apparent worsening with aging and low risk for chronic vascular complications. Despite the mild clinical course, GCK-MODY could be misdiagnosed as type 1 or type 2 diabetes. In the diagnostic process, the clinical suspicion is often based on the clinical diagnostic criteria for GCK-MODY and should be confirmed by DNA analysis. However, there are several issues in the clinical and also in genetic part that could complicate the diagnostic process. Most of the people with GCK-MODY do not require any pharmacotherapy. The exception are pregnant women with a fetus which did not inherit GCK mutation from the mother. Such a child has accelerated growth, and has increased risk for diabetic foetopathy. In this situation the mother should be treated with substitutional doses of insulin. Therefore, distinguishing GCK-MODY from gestational diabetes in pregnancy is very important. For this purpose, special clinical diagnostic criteria for clinical identification of GCK-MODY in pregnancy are used. This review updates information on GCK-MODY and discusses several currently not solved problems in the clinical diagnostic process, genetics, and treatment of this type of monogenic diabetes.Keywords
This publication has 100 references indexed in Scilit:
- Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control StudiesPLOS ONE, 2013
- Identification and Functional Characterisation of Novel Glucokinase Mutations Causing Maturity-Onset Diabetes of the Young in SlovakiaPLOS ONE, 2012
- Brain Glucose Sensors Play a Significant Role in the Regulation of Pancreatic Glucose-Stimulated Insulin SecretionDiabetes, 2012
- The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetesDiabetologia, 2012
- ADe NovoWhole GCK Gene Deletion Not Detected by Gene Sequencing, in a Boy with Phenotypic GCK InsufficiencyCase Reports in Genetics, 2011
- Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of DiabetesDiabetes Care, 2010
- Identification of a Novel β-Cell Glucokinase (GCK) Promoter Mutation (−71G>C) That ModulatesGCKGene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in HumansDiabetes, 2009
- Extremes of Clinical and Enzymatic Phenotypes in Children With Hyperinsulinism Caused by Glucokinase Activating MutationsDiabetes, 2009
- Molecular Physiology of Mammalian GlucokinaseCellular and Molecular Life Sciences, 2008
- Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the youngDiabetologia, 2008